• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Reply to Editorial Comment on "Survival Outcomes and Temporal Trends of Nonsurgical Management vs Radical Cystectomy in Nonorgan-Confined Urothelial Bladder Cancer".

作者信息

Longoni Mattia, Rodriguez Peñaranda Natali, Marmiroli Andrea, Falkenbach Fabian, Le Quynh Chi, Nicolazzini Michele, Catanzaro Calogero, Goyal Jordan A, Puliatti Stefano, De Cobelli Ottavio, Graefen Markus, Chun Felix K H, Palumbo Carlotta, Schiavina Riccardo, Saad Fred, Shariat Shahrokh F, Moschini Marco, Gandaglia Giorgio, Montorsi Francesco, Briganti Alberto, Karakiewicz Pierre I

机构信息

Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, Québec, Canada; Division of Experimental Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy.

Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, Québec, Canada; Department of Urology, Ospedale Policlinico e Nuovo Ospedale Civile S. Agostino Estense Modena, University of Modena and Reggio Emilia, Modena, Italy.

出版信息

Urology. 2025 Jun;200:116-117. doi: 10.1016/j.urology.2025.04.020. Epub 2025 Apr 15.

DOI:10.1016/j.urology.2025.04.020
PMID:40246245
Abstract
摘要

相似文献

1
Reply to Editorial Comment on "Survival Outcomes and Temporal Trends of Nonsurgical Management vs Radical Cystectomy in Nonorgan-Confined Urothelial Bladder Cancer".对关于“非器官局限性尿路上皮膀胱癌非手术治疗与根治性膀胱切除术的生存结果及时间趋势”的社论评论的回复
Urology. 2025 Jun;200:116-117. doi: 10.1016/j.urology.2025.04.020. Epub 2025 Apr 15.
2
Editorial Comment on "Survival Outcomes and Temporal Trends of Nonsurgical Management vs Radical Cystectomy in Non-organ-confined Urothelial Bladder Cancer".
Urology. 2025 Jun;200:114-115. doi: 10.1016/j.urology.2025.04.006. Epub 2025 Apr 4.
3
Survival Outcomes and Temporal Trends of Non-Surgical Management Vs Radical Cystectomy in Non-Organ-Confined Urothelial Bladder Cancer.非器官局限性尿路上皮膀胱癌非手术治疗与根治性膀胱切除术的生存结果及时间趋势
Urology. 2025 Jun;200:107-113. doi: 10.1016/j.urology.2025.02.051. Epub 2025 Mar 6.
4
Utility of lymphadenectomy following cystectomy for non-urothelial bladder cancer: a systematic review.非尿路上皮膀胱癌膀胱切除术后淋巴结清扫术的效用：一项系统评价
Minerva Urol Nefrol. 2016 Apr;68(2):185-91. Epub 2015 Dec 18.
5
Systematic Review on the Fate of the Remnant Urothelium after Radical Cystectomy.根治性膀胱切除术后残余尿路上皮转归的系统评价
Eur Urol. 2017 Apr;71(4):545-557. doi: 10.1016/j.eururo.2016.09.035. Epub 2016 Oct 6.
6
A Genomic Classifier for Predicting Clinically Aggressive Luminal Bladder Tumors with Higher Rates of Pathological Up Staging.一种用于预测具有更高病理升级率的临床侵袭性 Luminal 膀胱癌的基因组分类器。
J Urol. 2020 Aug;204(2):239-246. doi: 10.1097/JU.0000000000000798. Epub 2020 Feb 14.
7
Does Neoadjuvant Chemotherapy Followed by Radical Cystectomy Improve the Survival of Muscle-Invasive Bladder Cancer in Real-World Clinical Practice?在真实世界临床实践中，新辅助化疗后行根治性膀胱切除术能否提高肌层浸润性膀胱癌的生存率？
Int J Urol. 2025 Jul;32(7):830-838. doi: 10.1111/iju.70064. Epub 2025 Apr 11.
8
Utilization of Neoaduvant Chemotherapy and Oncological Outcomes in Patients Undergoing Radical Cystectomy for Variant Histology Versus Pure Urothelial Bladder Cancer - A Retrospective Comparative Cohort Study.
Indian J Surg Oncol. 2025 Jun;16(3):753-761. doi: 10.1007/s13193-024-02138-y. Epub 2024 Nov 28.
9
Follow-up of the Urethra and Management of Urethral Recurrence After Radical Cystectomy: A Systematic Review and Proposal of Management Algorithm by the European Association of Urology-Young Academic Urologists: Urothelial Carcinoma Working Group.根治性膀胱切除术后尿道的随访及尿道复发的处理：欧洲泌尿外科学会-青年学术泌尿外科医生尿路上皮癌工作组的系统评价及处理算法建议
Eur Urol Focus. 2022 Nov;8(6):1635-1642. doi: 10.1016/j.euf.2022.03.004. Epub 2022 Mar 23.
10
The impact of histopathological evaluation at transurethral resection of bladder tumour on survival in radical cystectomy candidates.经尿道膀胱肿瘤切除术的组织病理学评估对拟行根治性膀胱切除术患者生存的影响。
BJU Int. 2025 Aug;136(2):336-343. doi: 10.1111/bju.16714. Epub 2025 Mar 26.

引用本文的文献

1
Cancer-Specific Mortality of Partial Cystectomy Versus Radical Cystectomy in T2N0M0 Urothelial Bladder Cancer.T2N0M0期尿路上皮膀胱癌行部分膀胱切除术与根治性膀胱切除术的癌症特异性死亡率
Ann Surg Oncol. 2025 May 27. doi: 10.1245/s10434-025-17488-2.
2
Oncological outcomes after non-surgical management versus radical cystectomy in non-organ-confined non-urothelial bladder cancer.非器官局限性非尿路上皮膀胱癌非手术治疗与根治性膀胱切除术后的肿瘤学结局
Int Urol Nephrol. 2025 May 7. doi: 10.1007/s11255-025-04566-3.